WO2001091700A8 - Composition et procede destine a ameliorer l'elasticite des tissus - Google Patents

Composition et procede destine a ameliorer l'elasticite des tissus

Info

Publication number: WO2001091700A8
Authority: WO; WIPO (PCT)
Prior art keywords: tissue; composition; enhancing elasticity; enhancing; elasticity
Prior art date: 2000-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

PCT/US2001/017384

Other languages

English (en)

Other versions

WO2001091700A2 (fr

Inventor

Thomas F Mitts

Lawrence B Sandberg

Felipe Jimenez Jr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Connective Tissue Imagineering LLC

Original Assignee

Connective Tissue Imagineering LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-30

Filing date

2001-05-30

Publication date

2003-11-20

2000-05-30 Priority claimed from US09/580,893 external-priority patent/US6794362B1/en

2000-05-30 Priority claimed from US09/580,156 external-priority patent/US6962904B1/en

2000-05-30 Priority claimed from US09/584,001 external-priority patent/US6506731B1/en

2000-05-30 Priority claimed from US09/580,110 external-priority patent/US6809075B1/en

2001-05-30 Priority to AU2001275018A priority Critical patent/AU2001275018B2/en

2001-05-30 Priority to AU7501801A priority patent/AU7501801A/xx

2001-05-30 Priority to CA002415225A priority patent/CA2415225A1/fr

2001-05-30 Application filed by Connective Tissue Imagineering LLC filed Critical Connective Tissue Imagineering LLC

2001-05-30 Priority to IL15368701A priority patent/IL153687A0/xx

2001-05-30 Priority to EP01941684A priority patent/EP1392346A4/fr

2001-05-30 Priority to NZ523403A priority patent/NZ523403A/en

2001-12-06 Publication of WO2001091700A2 publication Critical patent/WO2001091700A2/fr

2002-11-30 Anticipated expiration legal-status Critical

2003-01-29 Priority to NO20030454A priority patent/NO20030454D0/no

2003-11-20 Publication of WO2001091700A8 publication Critical patent/WO2001091700A8/fr

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Cosmetics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PCT/US2001/017384 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus Ceased WO2001091700A2 (fr)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
NZ523403A NZ523403A (en)	2000-05-30	2001-05-30	Compounds that increase tissue elasticity and turgor which are analogous to portions of elastin
EP01941684A EP1392346A4 (fr)	2000-05-30	2001-05-30	Composition et procede destine a ameliorer l'elasticite des tissus
IL15368701A IL153687A0 (en)	2000-05-30	2001-05-30	Composition and method for enhancing elasticity of tissue
AU2001275018A AU2001275018B2 (en)	2000-05-30	2001-05-30	Composition and method for enhancing elasticity of tissue
AU7501801A AU7501801A (en)	2000-05-30	2001-05-30	Composition and method for enhancing elasticity of tissue
CA002415225A CA2415225A1 (fr)	2000-05-30	2001-05-30	Composition et procede destine a ameliorer l'elasticite des tissus
NO20030454A NO20030454D0 (no)	2000-05-30	2003-01-29	Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US09/580,893 US6794362B1 (en)	2000-05-30	2000-05-30	Asparagine containing elastin peptide analogs
US09/580,110		2000-05-30
US09/584,001		2000-05-30
US09/580,110 US6809075B1 (en)	2000-05-30	2000-05-30	Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,893		2000-05-30
US09/580,156		2000-05-30
US09/584,001 US6506731B1 (en)	1998-03-13	2000-05-30	Elastin peptide analogs and methods of using same
US09/580,156 US6962904B1 (en)	1998-03-13	2000-05-30	Elastin peptide analogs and uses thereof

Publications (2)

Publication Number	Publication Date
WO2001091700A2 WO2001091700A2 (fr)	2001-12-06
WO2001091700A8 true WO2001091700A8 (fr)	2003-11-20

Family

ID=27504943

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/US2001/017384 Ceased WO2001091700A2 (fr)	2000-05-30	2001-05-30	Composition et procede destine a ameliorer l'elasticite des tissus

Country Status (7)

Country	Link
EP (1)	EP1392346A4 (fr)
AU (2)	AU7501801A (fr)
CA (1)	CA2415225A1 (fr)
IL (1)	IL153687A0 (fr)
NO (1)	NO20030454D0 (fr)
NZ (1)	NZ523403A (fr)
WO (1)	WO2001091700A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2827170B1 (fr) *	2001-07-13	2004-07-16	Soc Extraction Principes Actif	Utilisation de peptides pour augmenter l'adhesion cellulaire
EP1434561A1 (fr) *	2001-10-05	2004-07-07	Procyte Corporation	Compositions de soins de la peau contenant des complexes peptidiques au cuivre, du retinol, des derives de retinol ou un melange de ces derniers
EP1434563A1 (fr) *	2001-10-05	2004-07-07	Procyte Corporation	Procedes de traitement de l'hyperpigmentation de la peau
US20040138103A1 (en) *	2002-11-07	2004-07-15	Procyte Corporation	Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (de) *	2002-12-20	2004-07-08	Henkel Kgaa	Verfahren zur Bestimmung von Markern humaner Gesichtshaut
US6927205B2 (en) *	2003-04-28	2005-08-09	Procyte Corporation	Compositions and methods for treatment of psoriasis
FR2854897B1 (fr) *	2003-05-12	2007-05-04	Sederma Sa	Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
WO2006004787A1 (fr) *	2004-06-28	2006-01-12	Procyte Corporation	Procédés et composition pour la prévention et le traitement de l’hyperpigmentation de la peau
CA2652388A1 (fr)	2006-05-15	2007-11-22	Valio Ltd	Nouvelle utilisation de peptides therapeutiquement utiles
WO2008100789A2 (fr)	2007-02-16	2008-08-21	Benaroya Research Institute At Virginia Mason	Compositions et procédés pour modifier l'élastogenèse
ES2673672T3 (es)	2011-02-11	2018-06-25	The Regents Of The University Of Michigan	Composiciones tripeptídicas y su uso para el tratamiento de la diabetes
WO2012135651A1 (fr)	2011-03-31	2012-10-04	The Procter & Gamble Company	Systèmes, modèles et méthodes pour identifier et évaluer des agents dermatologiques servant à traiter les pellicules et la dermatite séborrhéique
US9920357B2 (en)	2012-06-06	2018-03-20	The Procter & Gamble Company	Systems and methods for identifying cosmetic agents for hair/scalp care compositions
WO2021075707A1 (fr)	2019-10-16	2021-04-22	주식회사 네이처센스	Peptide pour améliorer la mémoire et prévenir ou soulager un trouble cognitif, composition le contenant et son procédé de préparation
FR3116273B1 (fr) *	2020-11-17	2023-10-27	Sederma Sa	Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR102484277B1 (ko) *	2021-11-22	2023-01-04	대한켐텍 주식회사	피부 미용 개선용 원료 조성물의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4877805A (en) *	1985-07-26	1989-10-31	Kligman Albert M	Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (de) *	1997-04-11	1998-10-15	Targor Gmbh	Metallocen-Aminosäure- und Peptid-Komplexe
JP2002501496A (ja) *	1997-04-21	2002-01-15	シェーリングコーポレイション	哺乳動物サイトカイン；関連の試薬および方法
US6069129A (en) *	1998-03-13	2000-05-30	Mrs, Llc	Elastin derived composition and method of using same
CA2317919A1 (fr) *	1998-11-19	2000-05-25	Connective Tissue Imagineering Llc	Utilisation cosmetique ou dermatologique de steroides 7-hydroxylates seuls ou combines ave des peptides derives de l'elastine
AU784203B2 (en) *	1999-10-29	2006-02-23	Glaxosmithkline Biologicals S.A.	Neisserial antigenic peptides

2001
- 2001-05-30 IL IL15368701A patent/IL153687A0/xx unknown
- 2001-05-30 EP EP01941684A patent/EP1392346A4/fr not_active Ceased
- 2001-05-30 AU AU7501801A patent/AU7501801A/xx active Pending
- 2001-05-30 CA CA002415225A patent/CA2415225A1/fr not_active Abandoned
- 2001-05-30 WO PCT/US2001/017384 patent/WO2001091700A2/fr not_active Ceased
- 2001-05-30 NZ NZ523403A patent/NZ523403A/en active Application Filing
- 2001-05-30 AU AU2001275018A patent/AU2001275018B2/en not_active Ceased
2003
- 2003-01-29 NO NO20030454A patent/NO20030454D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1392346A4 (fr)	2006-10-25
IL153687A0 (en)	2003-07-06
NO20030454L (no)	2003-01-29
CA2415225A1 (fr)	2001-12-06
NZ523403A (en)	2005-04-29
AU7501801A (en)	2001-12-11
WO2001091700A2 (fr)	2001-12-06
NO20030454D0 (no)	2003-01-29
AU2001275018B2 (en)	2008-04-03
EP1392346A2 (fr)	2004-03-03

Publication	Publication Date	Title
EP1157707B8 (fr)	2004-12-15	Composition et procédé pour la déformation de tissus mous
AU2002230831A1 (en)	2002-04-29	Compositions of human proteins and method of use thereof
AU2001249967A1 (en)	2001-10-23	Composition and methods for tissue preservation
AUPR638101A0 (en)	2001-08-09	Composition and method for treatment of disease
AU2002241228A1 (en)	2002-10-03	Method and composition for treatment of skeletal dysplasias
AU2001270943A1 (en)	2001-12-24	Surgical instrument and method of using the same
AU2001271530A1 (en)	2002-01-14	Method of hard tissue repair
AU2001233081A1 (en)	2001-08-07	Composition for treatment of stress
AU2001281140A1 (en)	2002-02-18	Anti-plasmodium compositions and methods of use
WO2001091700A8 (fr)	2003-11-20	Composition et procede destine a ameliorer l'elasticite des tissus
AU2001271031A1 (en)	2002-01-30	Cosmetic compositions for reducing and method of using the same
AU2001274181A1 (en)	2001-12-17	Composition and method for biocide treatment of surfaces
AU2001286983A1 (en)	2002-03-13	Method of treatment
AU2001233932A1 (en)	2001-09-03	Method and composition
AU2962400A (en)	2000-08-25	Cleaner composition and method of use thereof
AU2001234831A1 (en)	2001-08-14	Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2001288291A1 (en)	2002-03-22	Paving and sealing composition and method of use
AU2003282593A1 (en)	2004-05-13	Polyphenolamine composition and method of use
AU4839100A (en)	2000-12-05	Methods of using and compositions comprising n-desmethylzolpidem
AU2001262177A1 (en)	2001-10-23	Method of treatment
AU2002239775A1 (en)	2002-06-03	Chemical-library composition and method
AU2001253469A1 (en)	2001-11-12	Compositions and methods for stabilizing modified tissue
HK1063738A (en)	2005-01-14	Composition and method for enhancing elasticity of tissue
AU2001249194A1 (en)	2001-10-03	Immunokine composition and method
AUPQ876400A0 (en)	2000-08-03	Compositions and method of using them

Legal Events

Date	Code	Title	Description
2001-12-06	AK	Designated states	Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW
2001-12-06	AL	Designated countries for regional patents	Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG
2002-01-30	121	Ep: the epo has been informed by wipo that ep was designated in this application
2002-11-07	REG	Reference to national code	Ref country code: DE Ref legal event code: 8642
2002-12-26	WWE	Wipo information: entry into national phase	Ref document number: 153687 Country of ref document: IL
2002-12-27	WWE	Wipo information: entry into national phase	Ref document number: 2001941684 Country of ref document: EP
2002-12-30	WWE	Wipo information: entry into national phase	Ref document number: 2001275018 Country of ref document: AU
2003-01-03	WWE	Wipo information: entry into national phase	Ref document number: 523403 Country of ref document: NZ
2003-01-06	WWE	Wipo information: entry into national phase	Ref document number: 2415225 Country of ref document: CA
2003-11-20	D17	Declaration under article 17(2)a
2004-03-03	WWP	Wipo information: published in national office	Ref document number: 2001941684 Country of ref document: EP
2005-04-04	NENP	Non-entry into the national phase	Ref country code: JP
2005-04-29	WWP	Wipo information: published in national office	Ref document number: 523403 Country of ref document: NZ
2005-08-11	WWG	Wipo information: grant in national office	Ref document number: 523403 Country of ref document: NZ